Delivery Order SPE2DR25D3301-SPE2DR26F18BK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a contract ceiling value of $1,886.52. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $6,711.86 and firm fixed pricing. This non-set-aside, competitively awarded contract is scheduled for completion by November 4, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract carries a ceiling value of $1,288.24 and has a firm fixed price structure with an ultimate completion date of November 17, 2025. The award was issued from the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a contract ceiling value of $1,046.06. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order valued at $2,327.58 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed price delivery order represents a small-value transaction from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work...
- The Defense Logistics Agency awarded a delivery order valued at $2,412.99 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.33 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector auto-injector packs (2-count) on November 11, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,209.36 on September 12, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-packs). This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open competition process. The contract is classified as a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of epinephrine 0.3 mg auto-injector packs at a firm fixed price of $2,700.84. This contract, with an ultimate completion date of October 31, 2025, represents a competitively awarded, non-set-aside delivery order executed under the company's existing Indefinite Delivery Contract with DLA. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18BKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,955.63 on November 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and requires completion by November 17, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime IDC vehicle serves as a comprehensive global pharmaceutical support platform enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The epinephrine auto-injectors are critical emergency medical supplies utilized across Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems to address anaphylactic reactions and acute medical emergencies requiring rapid intervention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/14/25 |